Craig A Clifford DVM, MS, DACVIM (Oncology)
Philip J. Bergman DVM, PhD, DACVIM-Oncology
Course Open: July 8-25, 2020
Real Time Sessions (RTS): Wednesday, July 15, 2020; 8:00-10:00 pm ET (USA)
Course RTS Times in Your Area: World Clock Converter Level and Prerequisites: This intermediate course will be open to veterinarians and veterinary technicians/technologists actively interested in how to remove a tumor and make sense of the histopathology.
VIN CE Course: Open to veterinarians and veterinary technicians/technologists. This course has been submitted for RACE approval for veterinarians and veterinary technicians/technologists. Course Information:
The course will cover the different goals that can be achieved with surgery when removing a tumor. It will go over the factors that are taken into account in deciding what is the best goal for a particular patient. These goals will in turn determine the aggressiveness of the surgery. Therefore the “doses” of surgery will be reviewed to understand the different levels of aggressiveness. The principles of to how remove a tumor will be covered in light of the biology of the tumors. Week 1 (Real Time Session July 15, 2020): Surgical Oncology and Histopathology
Presenters: Dr. Bernard Séguin, Dr. Craig A. Clifford, and Dr. Philip J. Bergman
Objectives: Upon completion of this session, the participant should be able to
- Understand the role of the clinician and pathologist and their respective duties when submitting a biopsy.
- Become familiar as to which information is a must on a pathology report.
- Describes times when more information is needed.
- Discuss the rationale use of specialized panels and markers.
- Understand the possible goals of surgery and how to decide which goal is best.
- Understand the different “doses” of surgery and when to use each one.
- Know and understand the rationale for principles of how to remove a tumor.
Required Textbook(s): There is no required textbook for this course. About the Presenters:
Bernard Seguin obtained his DVM from the University of Montreal. He performed a small animal internship at the University of Illinois and completed a Masters of Science and Small Animal Surgery Residency at Washington State University. He then went on to fulfill his Fellowship in Surgical Oncology at Colorado State University. He was on Faculty at the University of California, Davis, and Oregon State University and is currently a Professor of Surgical Oncology at the Flint Animal Cancer Center, Colorado State University. Dr. Seguin is an ACVS Founding Fellow of Surgical Oncology. Dr. Seguin has lectured regionally, nationally, and internationally. He is the author of numerous scientific articles and book chapters. He is the co-editor of the textbook Veterinary Surgical Oncology. Phil Bergman is the Director of Clinical Studies for VCA. He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center and the principal veterinary investigator for the canine melanoma vaccine (Oncept®), which was fully licensed in 2009. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011; from 1999 – 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (‘90-‘91) and returned to CSU for his medical oncology residency (‘91-‘94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (‘94-‘99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society. Craig Clifford is a medical oncologist and the Director of Clinical Studies for Hope Veterinary Specialists in Malvern PA. Dr. Clifford is a well renowned oncologist who has authored/co-authored over 60 papers and book chapters. He is a frequent lecturer at major veterinary meetings in the USA and internationally. Dr. Clifford has served on multiple committees within VCS, ACVIM, VSSO the Oncology Pathology Working Group. He is an advisory board member to both industry and foundation partners. Total CE Credit: 2
Tuition: Member $46 ($41 early bird special if enrolled by June 24, 2020)
Non-Member $110 ($99 early bird special if enrolled by June 24, 2020)
Prices are listed in US dollars. *Enroll in 2 or more Surgical Oncology courses on the same day and receive a 15% discount.
- ONCO112-0720: Intro to Surgical Oncology and Histopathology
- ONCO113-0720: Multimodal Approach to Intra-Abdominal Neoplasia
- ONCO114-0820: Multimodal Approach to Intra-Thoracic Neoplasia
- ONCO115-0820: Multimodal Approach to Mast Cell and Soft Tissue Neoplasia
- Enrollment qualifications: VIN CE courses are open to VIN member and non-member veterinarians. Veterinarians enrolling in a VSPN CE course must be a VIN member. Veterinary support staff must be a VSPN member to enroll in a VSPN CE or a VIN CE course open to VSPN member enrollment.
- Each enrollee must be able to receive emails from @vspn.org and @vin.com addresses. Email is our major form of communication with participants; personal emails are highly recommended rather than clinic/hospital email addresses.
- Each person is individually responsible for his/her own registration. To ensure that all information received is secure and correct, please do not enroll for a course on behalf of another individual.
- For further assistance call 800-846-0028 ext. 797 or email CEonVIN. Please include the course title, your full name, and contact information in your correspondence.
VIN Education Director VIN CE Services: CEonVIN
800-846-0028 or 530-756-4881; ext. 797
or direct line to VIN/VSPN from the United Kingdom: 01 45 222 6154
or direct line to VIN/VSPN from Australia: 02 6145 2357